新闻Morphictx is developing preclinical pipeline of other molecules for the treatment of autoimmune diseases, pulmonary hypertensive diseases, fibrotic diseases and cancer.Additionally, Morphic is developing a preclinical pipeline of other molecules for the treatment of autoimmune diseases, pulmonary hypertensive diseases, fibrotic diseases and cancer.
新闻Morphictx is developing integrins.Morphic is working on a class of proteins called integrins, which traffic T cells.
新闻Morphictx is developing treatment for inflammatory bowel disease on Jul 15th '24.Morphic is developing a treatment for inflammatory bowel disease.
